The Effect of Early Time-Restricted Eating vs. Later Time-Restricted Eating on Weight Loss and Metabolic Health: A Network Meta-Analysis of Randomized Controlled Trials.
The Effect of Early Time-Restricted Eating vs. Later Time-Restricted Eating on Weight Loss and Metabolic Health: A Network Meta-Analysis of Randomized Controlled Trials.
复制标题
早期限时饮食与后期限时饮食对减肥和代谢健康的影响:随机对照试验的网络荟萃分析。
DOI:
--
复制
发表时间:
2023
影响因子:
5.8
通讯作者:
Feng Liu
中科院分区:
文献类型:
--
作者:
Juanhong Liu;Pan Yi;Feng Liu
OBJECTIVE
It remains controversial on whether the choice of the daily eating window early or later in TRE intervention (early or later TRE) has different effects on weight loss and metabolic health. A network meta-analysis was performed to evaluate the efficacy between early and later TRE in adults with obesity or overweight.
METHODS
We searched PubMed, Embase, Web of Science, and Cochrane Library for randomized controlled trials (RCTs) published until Oct 16, 2022. We conducted a network meta-analysis to evaluate the efficacy of early and later TRE on body weight and metabolic parameters, including glycemic metabolism, blood pressure, and lipid profiles.
RESULTS
12 RCTs with 730 obese or overweight adults were included in this meta-analysis. Both early TRE and later TRE elicited moderate reductions in body weight and insulin resistance (HOMA-IR) when compared to non-TRE. Interestingly, early TRE showed more effectiveness than later TRE in improving insulin resistance (early vs. later TRE: -0.44, 95% CI, -0.86 to -0.02; P < 0.05), whereas no significant difference was detected in weight loss (early vs. later TRE: -0.31 kg; 95% CI, -1.15 to 0.53 kg; P >0 .05). In addition, early TRE rather than later TRE showed significant benefits in glycemic metabolism and blood pressure when compared to non-TRE. No significant differences between early and later TRE were observed for fasting blood glucose, blood pressure, and lipid profiles.
CONCLUSIONS
This meta-analysis suggests that people may choose early TRE for more effective weight management and metabolic benefits. Nevertheless, further large-scale RCTs are warranted to verify our findings.